These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32489737)

  • 1. Validation of the Khorana Score to Assess Venous Thromboembolism and Its Association with Mortality in Cancer Patients: A Retrospective Community-based Observational Experience.
    Ahmed G; Nasir HG; Hall K; Weissmann L
    Cureus; 2020 Apr; 12(4):e7883. PubMed ID: 32489737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Khorana Score for Prediction of Venous Thromboembolism After Robot-Assisted Radical Cystectomy.
    Iqbal U; Elsayed AS; Ozair S; Jing Z; James G; Li Q; Hussein AA; Guru KA
    J Endourol; 2021 Jun; 35(6):821-827. PubMed ID: 33218263
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
    Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors.
    Icht O; Darzi N; Shimony S; Jacobi O; Reinhorn D; Landman Y; Mutai R; Averbuch I; Shochat T; Spectre G; Raanani P; Rotem O; Dudnik E; Peled N; Zer A; Leader A
    J Thromb Haemost; 2021 May; 19(5):1250-1258. PubMed ID: 33605020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels.
    Khorana AA; Kuderer NM; McCrae K; Milentijevic D; Germain G; Laliberté F; MacKnight SD; Lefebvre P; Lyman GH; Streiff MB
    Cancer Med; 2020 Nov; 9(21):8062-8073. PubMed ID: 32954653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare costs of patients with cancer stratified by Khorana score risk levels.
    Khorana AA; Kuderer NM; McCrae K; Milentijevic D; Germain G; Laliberté F; MacKnight SD; Lefebvre P; Lyman GH; Streiff MB
    J Med Econ; 2021; 24(1):866-873. PubMed ID: 34181497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
    Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
    Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
    J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
    Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
    J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Visco C; Contino L; Ciccone G; Ladetto M
    Thromb Res; 2016 Apr; 140 Suppl 1():S177. PubMed ID: 27161692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer.
    Piver RN; Wagner VM; Levine MD; Backes FJ; Chambers LJ; Cohn DE; Copeland LJ; Cosgrove CM; Nagel CI; O'Malley DM; Bixel KL
    Gynecol Oncol Rep; 2023 Apr; 46():101156. PubMed ID: 36910448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
    Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
    JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
    Tsubata Y; Kawakado K; Hamai K; Furuya N; Yokoyama T; Saito R; Nakamura A; Masuda T; Hamaguchi M; Kuyama S; Honda R; Senoo T; Nakanishi M; Hotta T; Yamasaki M; Ishikawa N; Fujitaka K; Kubota T; Kobayashi K; Isobe T
    Int J Clin Oncol; 2023 Jan; 28(1):69-78. PubMed ID: 36357710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing hypercoagulability and VTE risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy.
    Tera Y; Suh YJ; Fainchtein K; Agrawal A; Mates M; Othman M
    Am J Hematol; 2024 Apr; 99 Suppl 1():S19-S27. PubMed ID: 38425173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predicting the Incidence of Venous Thromboembolism Using the Khorana Score: A Literature Review].
    Nishimura A; Ikeda Y
    Yakugaku Zasshi; 2021; 141(4):611-622. PubMed ID: 33790126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma.
    Sanfilippo KM; Carson KR; Wang TF; Luo S; Edwin N; Kuderer N; Keller JM; Gage BF
    Res Pract Thromb Haemost; 2022 Jan; 6(1):e12634. PubMed ID: 35028491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
    Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a
    Barni S; Rosati G; Lonardi S; Pella N; Banzi M; Zampino MG; Dotti KF; Rimassa L; Marchetti P; Maiello E; Artioli F; Ferrari D; Labianca R; Bidoli P; Zaniboni A; Sobrero A; Iaffaioli V; De Placido S; Frassineti GL; Ciarlo A; Buonadonna A; Silvestris N; Piazza E; Pavesi L; Moroni M; Clerico M; Aglietta M; Giordani P; Galli F; Galli F; Petrelli F
    Ther Adv Med Oncol; 2020; 12():1758835919899850. PubMed ID: 32010236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.